Sperm DNA Fragmentation Detection Using Normalized Gamma-H2AX
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current semen analysis methods fail to reliably detect sperm DNA double-strand fragmentation, leading to inaccurate diagnoses of male infertility and suboptimal assisted reproduction outcomes.
Innovation Solution
A method involving the assessment of gamma-H2AX and H2AX expression in sperm samples, normalized to account for immature sperm cells, providing a more precise diagnosis of male infertility and fertility status by using a normalized expression value and coefficient of variation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional semen analysis methods are used, then the evaluation of male fertility is simple and routine, but sperm DNA double-strand fragmentation cannot be detected reliably
Solution Approach 1:
The patent replaces conventional mechanical/seminogram analysis methods with a molecular biology-based detection system using gamma-H2AX immunofluorescence staining and flow cytometry. This substitution enables reliable detection of sperm DNA double-strand fragmentation by detecting phosphorylated H2AX protein markers at the site of DNA breaks, achieving high measurement precision for DNA damage detection.
Solution Approach 2:
The patent introduces gamma-H2AX protein as an intermediary marker to indirectly detect sperm DNA fragmentation. Instead of directly visualizing DNA breaks, the method detects the phosphorylated H2AX protein that accumulates at DNA damage sites, serving as a reliable proxy indicator for sperm DNA integrity assessment.
2Measurement precision
If gamma-H2AX expression is assessed without normalization, then DNA fragmentation can be detected, but immature sperm cells with high H2AX expression cause false positives
Solution Approach 1:
The patent transforms the diagnostic parameter from absolute gamma-H2AX expression levels to a normalized ratio of gamma-H2AX to total H2AX expression. This parameter change eliminates the confounding effect of immature sperm cells with high baseline H2AX, enabling accurate distinction between true DNA fragmentation and normal developmental H2AX expression patterns.
Solution Approach 2:
The patent implements a feedback mechanism by measuring total H2AX expression and using it to normalize gamma-H2AX values. This internal reference system provides real-time correction for variations in H2AX expression levels, ensuring that DNA fragmentation detection is not confounded by changes in overall H2AX abundance during sperm maturation.
Data Source
AI summary
The present invention refers to the fertility field. Particularly, the present invention refers to an in vitro method for the diagnosis of male infertility, or for the identification of the fertility status of a subject compared to a reference group, to an in vitro method for recommending a fertility treatment to a subject, and to an in vitro method for assessing DNA fragmentation in a biological sample obtained from a subject, which comprises assessing the expression of gamma-H2AX and H2AX in a sperm sample obtained from a subject, and processing the expression values to obtain a normalized expression value of gamma-H2AX with respect to the expression of H2AX.